NCT04680676View on ClinicalTrials.gov

A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 2, 2022

Primary Completion Date

June 26, 2023

Study Completion Date

September 25, 2023

Conditions
Arthritis, Psoriatic
Interventions
DRUG

BI 730357

BI 730357

DRUG

Placebo

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04680676 - A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis | Biotech Hunter | Biotech Hunter